--- title: "Mercury General | 8-K: FY2025 Q4 Revenue: USD 1.536 B" type: "News" locale: "en" url: "https://longbridge.com/en/news/276168244.md" datetime: "2026-02-17T21:10:53.000Z" locales: - [zh-CN](https://longbridge.com/zh-CN/news/276168244.md) - [en](https://longbridge.com/en/news/276168244.md) - [zh-HK](https://longbridge.com/zh-HK/news/276168244.md) --- > Supported Languages: [简体中文](https://longbridge.com/zh-CN/news/276168244.md) | [繁體中文](https://longbridge.com/zh-HK/news/276168244.md) # Mercury General | 8-K: FY2025 Q4 Revenue: USD 1.536 B Revenue: As of FY2025 Q4, the actual value is USD 1.536 B. EPS: As of FY2025 Q4, the actual value is USD 3.66, beating the estimate of USD 2.56. EBIT: As of FY2025 Q4, the actual value is USD 255.94 M. #### Financial and Operational Metrics The provided 8-K filing indicates that Mercury General Corporation issued a press release on February 17, 2026, announcing its financial results for the fourth quarter ended December 31, 2025. However, the actual financial and operational metrics, cash flow, unique metrics, and outlook/guidance are not detailed within this 8-K filing, but are instead referenced as being in Exhibit 99.1. Therefore, specific financial figures and forward-looking statements cannot be extracted from the given reference . ### Related Stocks - [Mercury General Corporation (MCY.US)](https://longbridge.com/en/quote/MCY.US.md) ## Related News & Research - [Average Smart Home Faces 30 Cyberattacks a Day - Mercury Insurance Shares How to Stay Protected | MCY Stock News](https://longbridge.com/en/news/281552173.md) - [Nanalysis Sets Date for Q4 and Full-Year 2025 Results Call](https://longbridge.com/en/news/281538578.md) - [Itaú Unibanco Files Q4 2025 Pillar 3 Risk and Capital Report With Strong Capital Ratios](https://longbridge.com/en/news/281508938.md) - [SunPower files to delay 10-K, expects significant upside changes in FY 2025 results](https://longbridge.com/en/news/281182236.md) - [Scinai Immunotherapeutics reports FY results](https://longbridge.com/en/news/281477360.md)